| |
| |
|
| Insider
Information: |
Jacob Leonard S |
| Relationship: |
Director |
| City: |
Blue Bell |
| State: |
PA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
1,000 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
1,000 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
2
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
2
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-2.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -23.8%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Bradley Pharmaceuticals Inc |
BDY |
Director |
2007-03-30 |
1,000 |
2007-03-30 |
0 |
Premium* |
|
|
Antares Pharma Inc |
ATRS |
Director |
2022-05-24 |
0 |
2007-08-20 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ATRS |
Antares Pharma Inc |
Director |
– • – |
2022-05-24 |
4 |
D |
$5.60 |
$955,220 |
D/D |
(170,575) |
0 |
0 |
- |
|
| ATRS |
Antares Pharma Inc |
Director |
– • – |
2021-08-27 |
4 |
D |
$4.00 |
$55,280 |
D/D |
(13,820) |
295,575 |
0 |
- |
|
| ATRS |
Antares Pharma Inc |
Director |
– • – |
2021-08-27 |
4 |
A |
$2.24 |
$55,281 |
D/D |
24,679 |
309,395 |
0 |
- |
|
| ATRS |
Antares Pharma Inc |
Director |
– • – |
2021-06-10 |
4 |
A |
$4.42 |
$139,999 |
D/D |
31,674 |
284,716 |
0 |
- |
|
| ATRS |
Antares Pharma Inc |
Director |
– • – |
2021-02-18 |
4 |
AS |
$5.05 |
$77,371 |
D/D |
(15,321) |
253,042 |
0 |
% |
|
| ATRS |
Antares Pharma Inc |
Director |
– • – |
2021-02-18 |
4 |
OE |
$2.24 |
$34,319 |
D/D |
15,321 |
268,363 |
0 |
- |
|
| ATRS |
Antares Pharma Inc |
Director |
– • – |
2020-06-11 |
4 |
A |
$2.73 |
$110,000 |
D/D |
40,293 |
253,042 |
0 |
- |
|
| ATRS |
Antares Pharma Inc |
Director |
– • – |
2019-12-09 |
4 |
S |
$4.62 |
$1,133,145 |
D/D |
(244,814) |
212,749 |
0 |
- |
|
| ATRS |
Antares Pharma Inc |
Director |
– • – |
2019-12-09 |
4 |
OE |
$1.60 |
$260,800 |
D/D |
160,000 |
377,563 |
0 |
- |
|
| ATRS |
Antares Pharma Inc |
Director |
– • – |
2019-10-31 |
4 |
OE |
$1.10 |
$22,000 |
D/D |
20,000 |
297,563 |
0 |
- |
|
| ATRS |
Antares Pharma Inc |
Director |
– • – |
2019-06-13 |
4 |
A |
$2.92 |
$109,999 |
D/D |
37,671 |
277,563 |
0 |
- |
|
| ATRS |
Antares Pharma Inc |
Director |
– • – |
2019-04-08 |
4 |
OE |
$0.53 |
$48,801 |
D/D |
92,078 |
331,970 |
0 |
- |
|
| ATRS |
Antares Pharma Inc |
Director |
– • – |
2019-04-08 |
4 |
AS |
$3.00 |
$276,243 |
D/D |
(92,078) |
239,892 |
0 |
- |
|
| ATRS |
Antares Pharma Inc |
Director |
– • – |
2018-03-29 |
4 |
OE |
$0.85 |
$27,546 |
D/D |
32,407 |
239,892 |
0 |
- |
|
| ATRS |
Antares Pharma Inc |
Director |
– • – |
2017-10-09 |
4 |
AS |
$4.05 |
$931,920 |
D/D |
(230,000) |
207,485 |
0 |
- |
|
| ATRS |
Antares Pharma Inc |
Director |
– • – |
2017-10-09 |
4 |
OE |
$0.50 |
$119,800 |
D/D |
218,600 |
407,485 |
0 |
- |
|
| ATRS |
Antares Pharma Inc |
Director |
– • – |
2017-04-04 |
4 |
AS |
$2.90 |
$63,112 |
D/D |
(21,762) |
218,885 |
0 |
- |
|
| ATRS |
Antares Pharma Inc |
Director |
– • – |
2017-04-04 |
4 |
OE |
$1.65 |
$35,907 |
D/D |
21,762 |
240,647 |
0 |
- |
|
| ATRS |
Antares Pharma Inc |
Director |
– • – |
2017-04-03 |
4 |
AS |
$2.88 |
$57,570 |
D/D |
(20,000) |
218,885 |
0 |
- |
|
| ATRS |
Antares Pharma Inc |
Director |
– • – |
2017-04-03 |
4 |
OE |
$1.65 |
$33,000 |
D/D |
20,000 |
238,885 |
0 |
- |
|
| ATRS |
Antares Pharma Inc |
Director |
– • – |
2016-12-01 |
4 |
AS |
$1.97 |
$39,416 |
D/D |
(20,000) |
218,885 |
0 |
- |
|
| ATRS |
Antares Pharma Inc |
Director |
– • – |
2016-12-01 |
4 |
OE |
$1.23 |
$24,600 |
D/D |
20,000 |
238,885 |
0 |
- |
|
| ATRS |
Antares Pharma Inc |
Director |
– • – |
2016-03-18 |
4 |
B |
$0.72 |
$36,000 |
D/D |
50,000 |
218,885 |
2.39 |
- |
|
| ATRS |
Antares Pharma Inc |
Director |
– • – |
2015-03-23 |
4 |
S |
$2.68 |
$51,188 |
D/D |
(19,100) |
168,885 |
0 |
- |
|
| ATRS |
Antares Pharma Inc |
Director |
– • – |
2015-03-20 |
4 |
S |
$2.69 |
$11,836 |
D/D |
(4,400) |
187,985 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
